Results 221 to 230 of about 172,801 (303)

NKX2-5 Mutation and ICD Implantation in a Pregnant AV Block Patient. [PDF]

open access: yesJACC Case Rep
Alhmouz MM   +7 more
europepmc   +1 more source

Real World Evidence Versus Randomised Controlled Trials: Is the Future of Nutritional Sciences Research in Electronic Health Records?

open access: yesNutrition Bulletin, EarlyView.
ABSTRACT Randomised controlled trials (RCTs) are the gold standard of research studies. They aim to recruit participants with similar characteristics and randomly assign them to a treatment or control/placebo arm. Due to randomisation, RCTs provide comprehensive, unbiased evidence about treatment efficacy and safety and examine cause‐and‐effect ...
Kathryn V. Dalrymple
wiley   +1 more source

Genetic Diagnoses Among Congenital Anomaly Cases in Europe: Data From the EUROCAT Network

open access: yesPaediatric and Perinatal Epidemiology, EarlyView.
ABSTRACT Background Surveillance of congenital anomaly prevalence over time can identify new teratogens. Anomalies with a genetic cause are excluded from the monitoring. Objectives We examined temporal changes in the proportion of genetic diagnoses among cases with a congenital anomaly.
Jorieke E. H. Bergman   +23 more
wiley   +1 more source

Infant Readmission With Severe Acute Respiratory Failure. [PDF]

open access: yesNeoreviews
McKay KG   +3 more
europepmc   +1 more source

Who Deserves Scarce Health and Education Resources? How Policy Context Shapes Target Group Deservingness

open access: yesPolicy Studies Journal, EarlyView.
ABSTRACT The social construction of target populations (SCTP) framework emphasizes the ways in which target populations' levels of political power and deservingness shape the allocation of policy benefits, but less attention has been devoted to the conditions under which the same target population may be considered deserving in one policy context but ...
Elizabeth Bell   +3 more
wiley   +1 more source

Retention of critical platelet hemostatic functions of amotosalen‐UVA pathogen‐reduced cryoprecipitated fibrinogen complex

open access: yesTransfusion, EarlyView.
Abstract Background Cryoprecipitate Anti‐Haemophilic Factor (CRYO‐AHF) is enriched for fibrinogen, VWF, FVIII, FXIII and fibronectin, but has short post‐thaw expiration due to risk of transfusion‐transmitted infection (TTI) limiting availability for rapid treatment.
Florian Tupin   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy